ENDS EVALI VALI THCVALI: Difference between revisions

*'''Despite the evidence, the CDC continues including ‘e-cigarettes’ in the name EVALI. This naming has affected news coverage and contributed to distorted consumer beliefs about the risks of nicotine vaping. Smokers are twice as likely to incorrectly identify nicotine e-cigarettes as the cause of EVALI than to correctly identify illicit, adulterated THC products.'''

*'''This increased perceived risk is associated with a 30% reduction in both e-cigarette demand and reduced use of e-cigarettes for smoking cessation.'''

***Acknowledgment: M.F.P. reports recent funding from the National Institutes of Health, Food and Drug Administration Center for Tobacco Products; American Cancer Society; Virginia Foundation for Healthy Youth; the University of Kentucky’s Institute for the Study of Free Enterprise; and Health Canada. N.A.R.'s research is primarily funded by the National Institutes of Health. She has also received research funding from and consulted with Achieve Life Sciences to evaluate an investigational smoking cessation medication. K.M.C. has served as a paid expert witness in litigation filed against cigarette manufacturers. J.F. has recently performed paid consulting for Johnson & Johnson pharmaceutical company on smoking cessation medicines and has received a research grant from the National Jewish Health (healthcare organization) on telephone smoking cessation counseling. His research on e-cigarettes is funded by the National Institutes of Health (NIDA). C.D. is a co-principal investigator for research conducted through the Center for the Assessment of Tobacco Regulations, which is funded by NIH/FDA. He is also an advisor to the Smoking Cessation Leadership Center at the University of California San Francisco relating to behavioral health and tobacco use. K.E.W.’s research is supported in part by a Tobacco Center of Regulatory Science grant to the University of Michigan and Georgetown University from the Food and Drug Administration and National Cancer Institute (award no. U54CA229974). T.M. is the acting Attorney General for the State of Iowa and is responsible for representing the state in any legal matters. The opinions expressed in this article are the authors’ own and do not necessarily reflect the views of any of the organizations and government agencies that have provided support to the authors.